EC
GILD icon

Eachwin Capital’s Gilead Sciences GILD Stock Holding History

Eachwin Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$3.05M Buy
38,575
+6,210
+19% +$504K 2.81% 12
2016
Q2 		$2.7M Buy
32,365
+693
+2% +$61.5K 2.57% 15
2016
Q1 		$2.91M Buy
31,672
+2,483
+9% +$224K 2.79% 13
2015
Q4 		$2.95M Buy
+29,189
New +$3.04M 2.95% 9

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eachwin Capital's GILD Position: Q3 2016 in Review

Eachwin Capital increased its Gilead Sciences (GILD) stake by 19% in Q3 2016, buying an estimated $504K and bringing the position to 38,575 shares worth $3.05M. The position accounts for 2.81% of the portfolio, ranked #12.

Eachwin Capital first reported a position in GILD in Q4 2015 and has held it in 4 quarters since. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Eachwin Capital held 38,575 shares of Gilead Sciences worth $3.05M as of Q3 2016.
  • Eachwin Capital bought 6,210 Gilead Sciences shares in Q3 2016, an estimated $504K.
  • Gilead Sciences made up 2.81% of Eachwin Capital's portfolio in Q3 2016, its #12 holding.
  • Eachwin Capital first reported a position in Gilead Sciences in Q4 2015 and has held it in 4 quarters since.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Eachwin Capital's 13F filing for Q3 2016, filed 14 Nov 2016.